Navigation Links
Poniard Pharmaceuticals Reports Second Quarter 2008 Financial Results and Corporate Update
Date:7/31/2008

as 27 weeks for platinum-refractory and -resistant SCLC patients, a population for which there are very few treatment options.

-- Colorectal Cancer: Completed enrollment in our randomized, controlled Phase 2 trial in patients with CRC and presented positive preliminary results from this study at ASCO. Preliminary data suggested that picoplatin given once every four weeks in combination with 5-fluorouracil and leucovorin in the FOLPI regimen may have similar anti-tumor activity to oxaliplatin in combination with 5-fluorouracil and leucovorin in the FOLFOX regimen, which is the current standard of care in the first-line treatment of CRC.

We also presented expanded and updated results from our Phase 1 dose-escalation study in patients with CRC treated with FOLPI treatment administered every two or four weeks. None of the patients treated with picoplatin at doses of up to a cumulative dose of 1,350 mg/m2 exhibited severe neuropathy (Grade 3 or 4) in 62 evaluable patients. Current use of FOLFOX in CRC patients is associated with substantial neurotoxicity related to increasing cumulative doses of oxaliplatin at greater than 800 mg/m2. In addition, nephrotoxicities and ototoxicities were rare and mild with the FOLPI regimen.

-- Prostate Cancer: Presented preliminary safety and efficacy at ASCO data from our ongoing Phase 2 clinical trial of picoplatin in combination with docetaxel and prednisone, the standard of care for the first-line treatment of HRPC. Results to date demonstrated that picoplatin can be safely administered at full-dose docetaxel. Prostate specific antigen levels, or PSA normalized in 23 percent of patients. The data also demonstrated that reductions in PSA of at least 50 percent were achieved in 69 percent of evaluable patients. This compares favorably to published docetaxel treatment PSA response rates of approximately 45 percent.

-- Ovarian and Other Advanced Solid Tumors: Announced positive safety and efficacy data at ASCO
'/>"/>

SOURCE Poniard Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9

Related medicine news :

1. Poniard Pharmaceuticals Announces Upcoming Conference Participation
2. Arena Pharmaceuticals to Present at the NewsMakers in the Biotech Industry Conference
3. Schering-Plough/Merck Pharmaceuticals Announce FDA Filing Acceptance of New Drug Application for Loratadine/Montelukast Tablet
4. Provectus Pharmaceuticals, Inc. Begins Phase 2 Clinical Trial for Metastatic Melanoma
5. Idenix Pharmaceuticals to Present at Two Upcoming Investor Conferences
6. Vista Partners Updates Coverage on Tapestry Pharmaceuticals
7. Transcept Pharmaceuticals, Inc. to Present at UBS 2007 Global Life Sciences Conference
8. Crystal Research Associates, LLC Issues Executive Informational Overview(R) (EIO(R)) on Tapestry Pharmaceuticals, Inc.
9. Amylin Pharmaceuticals to Webcast Corporate Overview During 43rd Annual Meeting of the European Association for the Study of Diabetes
10. Major Pharma Clinical Case Studies From Amgen, AstraZeneca, GSK, Intermune, Cephalon Inc, Sunesis Pharmaceuticals and Dartmouth Medical School During Fall Clinical Focused Programs
11. Provectus Pharmaceuticals, Inc. releases summary results of phase 1 metastatic melanoma study
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/18/2014)... 18, 2014) ― A new study in the ... in health-related Google searches reveals a recurring pattern that ... , Investigators from San Diego State University, the ... Campaigns, analyzed "healthy" Google searches (searches that included the ... originating in the U.S. from 2005 to 2012. They ...
(Date:4/17/2014)... PHILADELPHIA The presence of chronic inflammation in ... aggressive, prostate cancer, and this association was found ... levels, according to a study published in ... of the American Association for Cancer Research. , ... some participants of the placebo arm of the ...
(Date:4/17/2014)... targets that could be used to provide relief ... London made the discovery when researching how pain ... body. , Dr Marzia Malcangio said: "We have ... and our findings could help chemotherapy patients who ... side effect of some chemotherapy drugs (such as ...
(Date:4/17/2014)... Biology and Medicine a multidisciplinary research team ... in the Institute of Genomic Biology (IGB) on ... describe their recent work on subcellular redox homeostasis. ... functions including energy metabolism, signaling, and transcriptional processes. ... cellular behavior, redox status has been recognized as ...
(Date:4/17/2014)... published in the April issue of Immunity , ... for Medical Research, says it,s time to take a ... treating sepsis, which kills millions worldwide every year, ... molecules released into the bloodstream to fight an injury ... necessary for maintaining good health without inflammation, wounds ...
Breaking Medicine News(10 mins):Health News:New research shows people are thinking about their health early in the week 2Health News:Chronic inflammation may be linked to aggressive prostate cancer 2Health News:Chronic inflammation may be linked to aggressive prostate cancer 3Health News:New pain relief targets discovered 2Health News:Live cell imaging reveals distinct alterations of subcellular glutathione potentials 2Health News:Feinstein Institute researcher publishes new perspective on sepsis 2
... Md., June 25 Trauma Solutions, a company developing ... simultaneously inducing blood clotting and delivering therapeutics, has been ... and Cisco Systems Global Business Plan Competition. , ... Casey and Keystone Professor Peter Kofinas, both from the ...
... play a role, researcher suggests , THURSDAY, June 25 ... children are more likely to develop cancer than those ... The University of Toronto researchers concluded that childhood physical ... of cancer in adulthood. Even after taking into account ...
... 2009) The AGA Foundation for Digestive Health and ... the first recipient of the Mary Terese Hartzheim Award ... created for young investigators interested in researching carcinoid or ... General Hospital and an instructor of medicine at Harvard ...
... ... Dictation Tips for Physicians: Technique, technology: powerful partners for creating high quality medical transcriptions. ... Scottsdale, AZ, ... are revolutionizing how we record and store medical information, but a physician,s dictation technique ...
... available in German . , Providing ... time- and labor-intensive molecular-biological procedures. Established methods are particularly ... is very low, for example during a phase of ... of micro-pumps without movable parts, scientists from the Fraunhofer ...
... NJ-ACEP Applaud Lawmaker for Putting Patients First , , ... Assemblyman Joe Cryan (D-Union) for sponsoring legislation that will improve ... for these vulnerable patients. , , Surveys have shown ... hospital emergency departments awaiting transfer to an appropriate behavioral health ...
Cached Medicine News:Health News:University of Maryland Company Trauma Solutions Named Finalist in $250K Draper Fisher Jurvetson and Cisco Systems Global Business Plan Competition 2Health News:University of Maryland Company Trauma Solutions Named Finalist in $250K Draper Fisher Jurvetson and Cisco Systems Global Business Plan Competition 3Health News:Abused Kids Face Higher Cancer Risk 2Health News:The AGA Foundation awards grant to Dr. Michael Choi to further his research on carcinoid tumors 2Health News:Medical Transcription Services Company MxSecure, Inc. Announces Top Ten Dictation Tips for Physicians 2Health News:Medical Transcription Services Company MxSecure, Inc. Announces Top Ten Dictation Tips for Physicians 3Health News:Virus filters for medical diagnosis 2Health News:Bills Address Long Waits for Behavioral Health Patients 2Health News:Bills Address Long Waits for Behavioral Health Patients 3
(Date:1/14/2014)... Jan. 14, 2014 /PRNewswire-iReach/ -- Acumed,s new SLIC Screw ... with accompanying instrumentation to place and insert the screw ... soft tissue (e.g. ligament) repair or reconstruction as it ... (Photo: http://photos.prnewswire.com/prnh/20140114/MN45636 ) ...
(Date:1/14/2014)... 14, 2014 NineSigma , Inc., the leading ... Innovation Leadership Summit , May 14-16, 2014 at the ... Ohio . This is the ... to breakthrough achievements through open innovation. Participants will learn ...
(Date:1/14/2014)... , Jan. 14, 2014   Evidera , a leading ... that the Center for Drug Evaluation and Research (CDER), ... draft qualification guidance document for a patient-reported outcome (PRO) ... Chronic Pulmonary Disease Tool [EXACT] for Measurement of Symptoms ...
Breaking Medicine Technology:Acumed introduces the Scapho-Lunate Inter Carpal (SLIC) Screw System 2Acumed introduces the Scapho-Lunate Inter Carpal (SLIC) Screw System 3Expect the Unexpected from Leading Global Innovators at NineSigma Leadership Summit, Sharing Winning Strategies to Advance Innovation 2Expect the Unexpected from Leading Global Innovators at NineSigma Leadership Summit, Sharing Winning Strategies to Advance Innovation 3Expect the Unexpected from Leading Global Innovators at NineSigma Leadership Summit, Sharing Winning Strategies to Advance Innovation 4Evidera Announces Release of FDA Draft Guidance on Use of the "EXACT" to Measure Symptoms of COPD Exacerbations 2Evidera Announces Release of FDA Draft Guidance on Use of the "EXACT" to Measure Symptoms of COPD Exacerbations 3Evidera Announces Release of FDA Draft Guidance on Use of the "EXACT" to Measure Symptoms of COPD Exacerbations 4
... As global food insecurity reaches all-time highs, Elanco seeks ... impact this growing crisis. Today, the company announced its ... a partnership with Heifer International. Elanco, ... global pharmaceutical corporation, is also dedicated to helping create ...
... IDEV Technologies, Inc. (IDEV) today announced the completion of ... evaluating the use of IDEV,s SUPERA® stent system for ... artery (SFA).  Enrollment was completed in May, making SUPERB ... The trial is a prospective, single-arm study of 258 ...
Cached Medicine Technology:Elanco Announces Commitment to Fight World Hunger 2Elanco Announces Commitment to Fight World Hunger 3IDEV Technologies Announces Completion of SUPERB Clinical Trial Enrollment 2
Rapid Infectious Mononucleosis Heterophile Antibody (IgM) Test...
... The Accutest Infectious Mononucleosis Whole Blood ... used for the detection of IgM ... in human whole blood. This test ... in the diagnosis of IM in ...
... ZstatFlu is the first available point-of-care ... diagnose all strains of influenza A and ... for influenza neuraminidase, an enzyme that assists ... the virus from infected cells. The ZstatFlu ...
The NOW® Flu B test is the most frequently adopted rapid flu test on the market today. Testing could not be easier and the results are available in 15 minutes. Now you can focus on the results an...
Medicine Products: